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Previous reports from this  laboratory have pointed out  the importance of 
agar precipitin technics as tools for the analysis of human streptococcal infec- 
tions, as well as of infectious diseases generally (1-6). The use of human conva- 
lescent serum as antibody source  enabled  the  estimation  of  the  number  of 
toxins  or  antigens  released  by  the  microorganism  in  the  tissues  during  the 
course of the illness. The same system also enabled us to follow the purification 
of each of the antigens thus shown to be produced in rico. Our studies have 
revealed that a  very large number of streptococcal extracellular antigens were 
demonstrable with human sera or gamma globulin, but very few cellular prod- 
ucts  appeared  to  reach  antibody-forming  sites  in  significant  amounts.  For 
this reason, much of the recent effort in this laboratory has been devoted to the 
purification of the extracellular streptococcal components. Thus far, approxi- 
mately nine of the twenty antigens detected with human gamma globulin have 
been purified to a greater or lesser degree. 
The ultimate goal of these studies was to examine the pathogenetic and biologi- 
cal  significance  of each  isolated  antigen  and  to  determine  its  identity and 
properties. The present report records the first  attempt to assess  the patho- 
logical  significance of some  of these  components.  Particular  stress  has  been 
placed on streptolysin O because of its possible significance in the pathogenesis 
of rheumatic fever.  Several of  the  other  separated  antigens  have also  been 
tested for their systemic effects. 
Rheumatic fever is well known to be preceded by streptococcal infections, 
and strong evidence indicates that this microorganism causes the disease  (7). 
The precise mechanism has never been established, however.  It has been sug- 
gested that rheumatic fever may be the result of an unusual intoxication by 
some product or products of the streptococcus (8), or that  hypersensitive  (9), 
or autoimmune mechanisms (10) are operative. Whatever the mechanism, the 
specific cause and effect relationship between streptococcal infection and rheu- 
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matic  fever makes it  extremely  likely that  some particular  substance  of this 
microorganism is etiologically involved. Of the numerous known streptococcal 
toxins  or antigens,  circumstantial  evidence has  accumulated  in  the  literature 
which is  compatible  with  the  speculation that streptolysin  0  may be a  factor 
involved in the production of cardiac lesions. These lines of evidence are: 
I.  Bernheimer and Cantoni (11) first showed that the frog heart is very susceptible 
to this in vitro.  Kellner, Bernheimer et al.  (12)  then demonstrated that the isolated 
rabbit heart is extremely sensitive to very small concentrations of this substance in 
vitro,  when perfused  through the  coronary arteries.  Under  these  circumstances,  ir- 
reversible  cardiac standstill  occurred.  These  studies  were  carried  out with  concen- 
trates of unknown complexity. 
2.  Schwab et al.  (13)  observed that rabbits pretreated  with certain streptococcal 
factors developed a high incidence of focal cardiac lesions  upon subsequent injection 
of streptolysin 0 containing culture filtrates. They presented evidence that streptolysin 
0 was the substance causing the heart lesions. 
3.  Murphy and Swift (14) and others (15) have shown that repeated streptococcal 
infections of rabbits will  cause focal cardiac lesions.  Kirschner and I-Iowie (16)  con- 
firmed these reports, and found a  correlation between the incidence and severity of 
the heart lesions,  and the intensity of rise of the anfistreptolysin O titer of the serum. 
No such correlation  was found with the antihyaluronidase responses in these rabbits. 
4.  Streptolysin O is almost uniformly produced in vivo during the course of human 
streptococcal  disease,  as  evidenced  by  the  very  frequent  rises  of  antistreptolysin 
(ASO) titer following infections (7). 
5.  Patients with rheumatic fever tend to have higher antistreptolysin O titers than 
patients with uncomplicated streptococcal disease  (e.g.,  7, 17, 18). They also tend to 
reveal higher titers of some other antistreptococcal antibodies (e.g., references 19, 20). 
In response to non-streptococcal antigens, however, rheumatic patients do not produce 
more antibody than non-rheumatic subjects (21-23). These data therefore suggest a 
more intense antigenic stimulus in rheumatic patients during the  course of strepto- 
coccal infections, at least with streptolysin and several other secreted antigens. 
It is perhaps of some significance  that rheumatic fever recurrences can be prevented 
by curing streptococcal infections in the early stages with sufficient penicillin.  Enough 
penicillin  must  be  given  so  that  the  antibody  responses  (including  ASO)  will  be 
stifled  (24-26). 
6.  Coburn and Pauli (27) isolated 40 strains of hemolytic streptococci from cases of 
acute pharyngitis in 38 subjects with rheumatic fever. Infections by 20 of the strains 
resulted in rheumatic recurrences, while  infections with the other 20 did not. These 
investigators reported that practically all strains from infections resulting in rheumatic 
fever produced large quantities of streptolysin O in vitro.  Only 7 of the 20 "non-effec- 
tive" streptococci were found to produce smaller  quantities  of this substance under 
the  same  growth  conditions.  Parallel  results  were  obtained  with  reference  to  the 
synthesis of erythrogenic toxin. 
7.  Cholesterol is known to be a potent inhibitor of streptolysin O hemolysis (28). 
It has been shown that mice given injections of cholesterol (29), or detergents which 
will raise the blood cholesterol level (30) may be resistant to streptolysin O toxicity. S.  P.  HALBERT~ R.  BIRCItER,  AND  E.  DAHLE  761 
It has been stated  (31)  that  rheumatic patients with myxedema,  nephrosis, or 
diabetes meUitus seem refractory to  rheumatic fever recurrences. Hypercholesterol- 
emia is associated with these diseases. Patients with hyperthyroidism  (and hypo- 
cholesterolemia) were reported to show  increased susceptibility to rheumatic fever. 
Cobum (32) has reported that a diet producing hypercholesterolemia (egg yolk pow- 
der) will protect rheumatic subjects against rheumatic recurrences following strep- 
tococcal pharyngitis. 
In view of the above cited investigations, it was felt of importance to exam- 
ine the biological effects of the purified streptolysin O  in vivo, with special refer- 
ence to its cardiovascular effects.  A  preliminary description of these has been 
reported  (5).  The  present  study describes  the  detailed  changes  produced  in 
rabbits in acute  experiments with  streptolysin O  from  2  streptococcal  strains 
belonging to different serological groups, A and C. 
Materials  and  Methods 
One lyophilized streptolysin O fraction was prepared from the Group A streptococcal strain 
C203S, by a combination of continuous flow electrophoresis  and column chromatography re- 
ported previously (peak VII, Text-fig.  5 of reference 4). It revealed about 150,000 hemolytic 
units (HU)/mg. protein. Immtmologically, it showed  a  predominant precipitin band with 
streptolysin specificity, which titrated to high dilutions (0.012 mg./ml.) using human gamma 
globulin. It was contaminated by two other antigens in small amounts (at 1 mg./ml, only). 
One of these was identified as diphosphopyridine nucleotidase (DPNase) immunologically,  and 
the other is at present unidentified. 
The streptolysin O of the Group C strain was similar to that reported previously (3), but 
had been made from a different batch of culture filtrate and was of somewhat lower potency. 
It contained about 50,000 HU/mg. protein, but also was contaminated by small amounts of 
DPNase. No other antigens but these were detectable with human gamma globulin. The Group 
C streptolysin in the lyophilized state contained about 40 per cent by weight of non-protein 
material as estimated by ultraviolet absorption measurements. The dry weight of the Group A 
product appeared to be all protein. 
In all instances, the streptolysin was dissolved in 0.1 ~t sodium phosphate buffer at pH 7.2. 
Activation was carried out by adding l-cysteine-HCl  as a neutralized solution in the same buf- 
fer to a final concentration of 10 mg./ml. After warming at 30°C. for 10 minutes, it was kept 
in an ice bath until use, never later than 3 hours after preparation. 
The rabbits used in this study were albino of either sex, 2.6 to 3.2 kg. All were obtained from 
one breeder (Rockland Farms, New City). The injections were given intravenously into the 
marginal ear veins as rapidly as possible.  Most of the rabbits received  the same volumes of 
cysteine solution (10 mg./ml.) alone as a control, from 5 to 30 minutes prior to the administra- 
tion of the streptolysin dose (0.2 to 2 ml.). 
Other streptococcal fractions used included purified proteinase, prepared by cysteine treat- 
ment from precursor which had been 3 X  recrystalllzed and 1 X  rechromatographed (see ref- 
erence 4). Also tested was a fraction rich in desoxyribonuclease B, an "antigen excess" fraction 
containing only two antigens, one possibly related to erythrogenic toxin, and a possible com- 
plex of protein and C carbohydrate. In addition, five rabbits were given lethal doses of Skigdla 
paradysenteriae  type III endotoxin, prepared by the method of Goebel et al. (33). 
The cholesterol  suspension was prepared  according to the technic of Cohen et al.  (34). 
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from E. R. Squibb and Sons (Rahway, New Jersey). Its antistreptococcal antibody content has 
been reported (2-4). 
All rabbits were followed electrocardiographically, the electrodes being placed on the clean 
shaven limbs with pediatric  size metal contacts, in most instances. All of the animals were 
unanesthetized and were usually tied prone on their abdomens. On most of the recordings, the 
amplitude was adjusted so that 1 mv. =  1.15 cm. and the paper speed was 2.4 cm./sec. Stand- 
ard leads were tested, and those giving the optimal wave tracings were used. A high degree of 
variability was found between individual rabbits. 
In a number of cases, right and left fronto-occipital and transfrontal electroencephalograms, 
electrocardiograms (lead 2), and femoral arterial blood pressures were simultaneously recorded 
with a Grass polygraph model 5 (Grass Company, Quincy, Massachusetts).  The blood pres- 
sures were obtained  by means  of an indwelling catheter  implanted  under  local anesthesia 
using a strain gauge manometer. 
RESULTS 
Following intravenous injection of a lethal dose of streptolysin O, the rabbits 
rapidly  developed  a  series  of  motor  convulsions,  with  the  head  in  extreme 
extension.  Respiratory  arrest  usually  followed  the  convulsions,  and  in  most 
instances,  death occurred in less than 5 minutes. 
The results  of the toxicity assays are shown in Table I, which also records 
the time elapsed until the first convulsive seizure. It may be seen that the LDs0 
of the Group A concentrate is about 0.15 mg. dry weight, as compared to 0.75 
mg. of the Group C concentrate. This latter figure represented  about 0.45  rag. 
protein,  and  the  difference in lethal  end-point  correlated  fairly well  with  the 
hemolytic potencies  of the  fractions.  In addition,  the  clinical  manifestations 
were  precisely  the  same  with  both  preparations.  The  sharpness  of  the  end- 
point  for  both,  and  the  similarity  of  the  time  required  for  convulsions  are 
evident. 
Electrocardiographic Effects of Large Lethal Doses of Streptolysin.--Profound 
electrocardiographic changes could be observed within 3 to 5 seconds following 
the injection of 3  to 6 multiples of the LDs0. Examples of these are shown in 
Text-figs. 1 and 2 for the Group A and Group C fractions, respectively. In three 
instances  (Text-figs.  la,  lb,  2a)  there  was an extremely rapid  transition  from 
a  normal  sinus  rhythm  to  ventricular  arrhythmia,  followed  by  ventricular 
fibrillation  and  standstill.  In  Text-fig.  2b,  a  similar  rapid  transition  from  a 
normal  sinus  rhythm  to  ventricular  arrhythmia  occurred.  Twenty-eight 
seconds  after  injection,  temporary  recovery apparently  took place,  with  AV 
dissociation  followed  by  sinus  tachycardia.  ST  depression  was  still  present, 
however,  and  51  seconds  after  injection  multifocal  ventricular  arrhythmia 
began, followed by standstill. 
Electrocardiographic Effects of Smaller Lethal Doses.--When smaller, but still 
lethal  doses  of  either  streptolysin  preparation  was  given  (1  to  2  LDs0),  the 
sequence of events was more prolonged. Examples of these are shown in Text- 
figs. 3 and 4 for the Group A and C fractions, respectively. It may be seen that TABLE  I 
Toxicity for Rabbits of Intravenous Activated Streptolysin 0 from 2 Streptococcal  Strains 
Toxicity for rabbits of reduced streptolysin O from streptococci  of 
Group A  Group C 
Dose  (dry wt.)*  Result  Time onset convulsions  Dose  (dry wt.)  Result  Time onset convulsions 
mg. 
1 
0.5 
0.25 
0.15 
0.1 
D 
D 
D 
D 
D 
D 
D 
D 
D 
D 
D 
D 
D 
D 
s§ 
I1 sec. 
15 sec. 
35  " 
65  " 
44 sec. 
62  " 
65  " 
95  " 
103  " 
180  " 
2 hrs.~: 
75 min. 
2 hrs.~ 
24  " 
mg. 
10 
2.5 
1.5 
1.25 
1.0 
0.75 
0.5 
0.23 
D 
D 
D 
11 sec. 
13 sec. 
23  " 
D  13 sec. 
D  30  " 
D  75  " 
D  90  " 
D 
D 
D 
D 
D 
D 
D 
D 
D 
D 
D 
D 
D 
D 
S 
D 
D 
S 
S 
16 sec. 
60  " 
63  " 
63  ~ 
106  " 
,56 sec; 
60  " 
65  " 
87  " 
129  " 
168  " 
36 sec. 
174  " 
45 min. 
32 sec. 
5 min. 
* The doses represent milligrams  of lyophilized powder. 
:~ Approximate times of death; convulsions may or may not have occurred. 
§ D, died; S, survived at least 2  days. 
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TExT-FIG. 2. Extremely rapid electrocardiographic effects produced by 2 and 3 LD~0 doses 
of Group C streptolysin O. The follow-up strips represent sample recordings at the time inter- 
vals noted, following completion of the injections. (a) 2.5 rag.  (b) 1.5 mg. 766  CARDIOTOXICITY OF STREPTOLYSIN O 
the changes were not always the same.  Common alterations found were AV 
nodal rhythm, depression of the ST segment, and T  wave elevation or depres- 
sion,  or  biphasic  T  waves.  Also  seen were  PQ  and  QRS  prolongation,  and 
decrease in the amplitude of the P waves and the QRS complex. Very temporary 
sinus  bradycardia was frequently noted for several seconds following the  in- 
jection. These changes were followed by ventricular extrasystoles, ventricular 
tachycardia,  ventricular flutter,  and  fibrillation,  with  eventual  standstill  of 
the heart. 
Electrocardiographic Effects  of Non-Lethal  Doses.--Of  the  thirteen  rabbits 
listed in Table I which received non-lethal doses (1/~ to 2/~ LDs0) of the strepto- 
lysin preparations,  often no  changes  in  behavior were  observed.  Sometimes 
they appeared somewhat sluggish for a period of up to several hours, but this 
never  seemed  to  be  severe.  Temporary  electrocardiographic  changes  were 
found in nine of these animals, however. Examples of these temporary changes 
are  found in  Text-fig. 5.  Sinus  tachycardia  (Text-fig. 5a),  sinus  arrhythmia 
(Text-fig. 5b), electrical alternans (Text-fig. 5c), diminution of the QRS ampli- 
tude  (Text-fig. 5c),  ST depression  (Text-figs. 5b,  c),  negative or biphasic  T 
waves  (Text-figs. 5c, e), as well as ventricular extrasystoles (Text-fig. 5a) or 
unifocal ventricular premature beats  (Text-fig. 5d) were present at times, but 
were reversible.  The ST segment  alterations  might  last  only a  few minutes 
(Text-fig. 5a) or for as long as several days (Text-fig. 5b). Runs of extrasystoles, 
as well as electrical alternans were seen in four of these animals. These changes 
lasted for 2 to 10 minutes. In three animals they began 5 to 10 minutes follow- 
ing the injection, but in one case, they were only detected at 18 hours (Text- 
fig. 5d). 
Controls.--In order to ascertain that the toxic effects were due to the strep- 
tolysin itself, the following series of control studies were carried out. 
Cysteine solution failed to cause any detectable changes whatsoever, even 
in the maximum doses used (20 mg./2ml.). For most of the streptolysin injec- 
tions a volume of 0.5 to 1.0 ml. was used, containing only 5 to 10 mg. of cysteine. 
Cysteine control injections were given to almost all of the rabbits 5 to 30 min- 
utes prior to the streptolysin dose. In the few which did not receive the pre- 
liminary  cysteine  control  dose,  the  toxicity  of  the  streptolysin  itself  was 
unaltered. 
Other Streptococcal Antigens and Shigella Endotoxin.--Four other extracellular 
Group  A  streptococcal antigen fractions which  had  been  separated  electro- 
phoretically and chromatographically in previous studies (4) were tested intra- 
venously. Only limited numbers of animals could be examined because of the 
shortage of materials. None of these showed any significant electrocardiographic 
changes. 
Two rabbits received 5 mg. each of a fraction containing only two detectable 
components, the "antigen excess" fractions. This material was similar  to  that TExT-FIG.  3.  More prolonged duration of electrocardiographic effects with smaller lethal 
doses of reduced Group A streptolysin O. 
767 TExT-FIG.  4.  More prolonged duration of electrocardiographic effects with smaller lethal 
doses of reduced Group C streptolysin O. 
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found in chromatographic peak II of Text-fig. 5 in reference 4. It may be  re- 
called that immunological evidence related one of those components to erythro- 
genic toxin. One animal was given this fraction after a solution of it was  pre- 
treated with cysteine, as for streptolysin O. Although these two rabbits showed 
no detectable electrocard/ographic changes up till 2  days, they died  5  and  6 
days following the injections. 
Two rabbits received 5 mg. each of a fraction rich in desoxyribonuclease B, 
but  also  containing some of the  "antigen excess" components  (peak III of 
Text-fig. 5 in reference 4). It is worth emphasizing that this fraction, which was TExT-FIG,  5.  Temporary electrocardiographic effects produced  by sublethal doses of re- 
duced active Group A or Group C streptolysin O. 
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devoid of hemolytic activity, was  obtained from the  same  chromatographic 
run as that which yielded the Group A streptolysin O used here. The DNAse 
B eluted in the step 0.01 ~  to 0.03 ~  phosphate, while the streptolysin eluted 
at 0.2 M and higher. One rabbit received the DNAse B dose after pretreatment 
with cysteine. This animal  survived, while the other died between 3  and  18 
hours after the injection. Neither showed ECG changes,  the  survivor being 
followed for 6 days. 
One rabbit received 5 mg. of an unadsorbed chromatographic fraction rich 
in an  apparent complex of carbohydrate and protein  (peak I  of Text-fig. 4, 
reference 4).  No  definite electrocardiographic abnormalities were found, and 
the animal survived. 
Three rabbits received 5 rag. of highly purified proteinase in 1 ml. This was 
activated from the precursor state by treatment with  10 mg. cysteine for 30 
minutes  at  30°C.;  these  conditions have  been  found  adequate  to  produce 
transformation  to  the  active  enzyme.  Interest  in  this  substance  was  great 
because of the report by Kellner and Robertson (35) that it causes focal cardiac 
necrosis in rabbits, mice, and guinea pigs. One rabbit was seen to die 19 hours 
following the injection, about 5 minutes after the final  electrocardiogram was 
recorded. No  striking electrocardiographic abnormalities occurred during  the 
postinjection period, although slight ST segment changes were seen terminally. 
Autopsy failed to reveal any gross lesions in the heart, or elsewhere. One  other 
rabbit died between 5 and 18 hours, while the third  survived. Neither showed 
any distinct ECG changes. 
Five  rabbits  received varying  lethal  amounts  of Shigella  paradysenteriae 
type III endotoxin. The doses used ranged from 1.25  mg. to 10 rag., the time 
for death with the latter being 3 hours. Other tests indicated that  the me.D. of 
this preparation was about 0.1 to 0.2 mg., so that the  doses used above repre- 
sented 10 to 100 M.L.D. No striking  alterations of the electrocardiograms were 
noted, but it was of some interest that undulations of  the recordings became 
quite extreme after about 1 hour due to accelerated respirations.  The rabbit, 
whose ECG is  shown  in  Text-fig. 6,  received 5  nag. of endotoxin,  and  died 
between 3 and 15 hours following the injection. 
State of Oxidation-Reduction of Streptolysin 0.--It is well known that streptoly- 
sin O  is a  reversibly oxidizable substance, and that  its  hemolytic activity is 
evident only in the reduced state (36-38). In addition, during  purification, it 
has been shown that streptolysin rapidly becomes reversibly oxidized to  the 
extent of 95 per cent or more. The lyophilized preparations used here were also 
largely in  this inactive configuration (about 95  per  cent)  and  it  was  felt of 
importance to  test  their  toxicity without cysteine reduction.  The results  of 
these tests are summarized in Table  II, which clearly shows  the  much  lower 
toxicity of  these  fractions  when  reversibly oxidized.  Roughly  7  to  8  times 
more was required to kill than when in the reduced condition. These observa- 
tions agree with those of Herbert and Todd (36) who reported limited data on S.  P.  HALBERT~  R.  BIRCIKER~  AND  E.  DAHLE  773 
TExT-Fro. 6. Lack of effect on the electrocardiogram  of a large lethal dose of endotoxin. 
TABLE II 
Toxicity for Rabbits of Reversibly Oxidized Streptolysin 0 
Toxicity of reversibly oxidized streptolysin  O 
Group A  (LD,0 reduced =  0.15  rag.)  Group C  (LDs0 reduced =  0.75  mg.) 
Dose of  Dose of 
oxidized form  Results  Time onset convulsions  oxidized form  Results  Time onset convulsions 
(dry wt.)  (dry wt.) 
mg. 
1.0 
0.5 
0.25 
D 
D 
85 min. 
2 to 18 hrs.* 
mg. 
8.0 
6.5 
D 
D 
143 sec. 
210 sec. 
5.0 
2.5 
D 
S 
S 
S 
S 
120 min. 
* Approximate time of death; convulsions may or may not have occurred. 
the lethal toxicity of streptolysin O  concentrates for mice in  the oxidized and 
reduced state. The differences in lethal dose they found  were of the same order 
of magnitude recorded here. Neither is quite as great as might be  expected on 
the basis of the proportion of oxidized streptolysin, as evidenced by hemolytic 
titration. It seems likely, however, that some reduction takes  place in vivo by 
the activity of blood or tissue cells.  Evidence for this is furnished by observa- 
tions  of Pillemer and  Ecker  (39)  showing  that  the  sulfhydryl-dependent en- 
zyme urease could be activated by the reducing potential of tissues. 
It was of some importance that  the injection  of  the oxidized streptolysin O 774 S.  P.  HALBERT~  R.  BIRCItER~  AND  E.  DAH~E  775 
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in lethal  doses caused electrocardiographic  changes similar to those seen with 
the activated fractions (see Text-figs. 7a and 7b). The time required for these 
changes to develop was longer than would be anticipated for the reduced form. 
In  addition,  several  of  the  rabbits  surviving  the  larger  non-lethal doses  of 
oxidized streptolysin O showed temporary ECG changes, such as the ventricular 
extrasystoles and bigeminal rhythm seen in Text-fig. 7c. In this latter rabbit, 
the  extra  beats  began about  3.5  minutes following the  injection, lasted for 
about 15 minutes, and then were only noted the next morning for a short while. 
Effects of CholesteroL--Further evidence that the toxic and lethal effects were 
due to streptolysin O was furnished by the tests with cholesterol, a well known 
potent inhibitor of this substance  (11).  Two rabbits received 0.5  mg. of the 
reduced Group A streptolysin (3 LDs0) that had been mixed with an aqueous 
4 X  crystallized cholesterol suspension and allowed to stand at room tempera- 
ture for 5 minutes. One animal was given 2.5 mg. and the other 3.8 mg. of 
cholesterol in the mixture. Both survived, the former showing extrasystoles for 
a period of 2 minutes, starting 11/~ minutes after the injection. A control rabbit 
given the same amount of this streptolysin solution, diluted with water and 
treated similarly, died with typical symptoms and electrocardiographic changes 
within 1 minute. Since diphosphopyridine nucleotidase has been shown to be 
unaffected by reducing agents, and by cholesterol (40),  these data furnished 
evidence that this minor contaminant was not involved in the reactions seen. 
Effect of Pooled Human  Gamma  Globulin.--Two  rabbits  were  given  intra- 
venous  injections  of  pooled  normal  human  gamma  globulin  rich  in 
antistreptolysin, one getting 2 ml. and the other 4 ml. (16  per cent solution). 
This was followed 5 minutes later by 1 ~.L.D. of the Group C reduced streptoly- 
sin O (1.25 mg.). These animals were apparently completely protected against 
the lethal and cardiac effects of the streptolysin. The control rabbit receiving 
the  same  challenge  without  the  human  antibodies  died  typically within  2 
minutes. 
Four rabbits were given 1 M.L.D. of the reduced Group A streptolysin (0.25 
mg.), 24 hours after receiving 4 ml. of the gamma globulin intraperitoneally. 
Three  of these also  received  1 ml.  of the  globulin intravenously 5  minutes 
prior to the challenge dose of streptolysin. Two of the latter survived, one with 
temporary ECG changes,  while the other  two died of streptolysin toxicity. 
Incidentally, in this series of experiments, two other rabbits were given 2 or 4 
ml. of the gamma globulin intravenously, and showed temporary electrocardio- 
graphic abnormalities from this alone. 
Blood  Pressure  and  Electroencephalographic  Data.--In  eight  rabbits  given 
lethal doses of streptolysin O, simultaneous recordings were made of the femoral 
artery  blood  pressure,  and  in three of  these,  electroencephalograms  (EEG) 
were also recorded. A  typical experiment  is  shown in Text-fig. 8.  The  blood 
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63 seconds, and then gradually to 25/25 ram. at 97 seconds. The electrocardio- 
gram showed the same sequence of changes seen in Text-figs. 3  and 4, from 
sinus rhythm to ventricular tachycardia, ventricular fibrillation, and  cardiac 
standstill. It is important to note that the electrocardiogram was  significantly 
altered at the time of the first decrease in blood pressure. The inversion  and 
widening of the QRS complexes at 54 seconds suggest that a ventricular con- 
duction defect was already present. In other rabbits,  the ECG  changes were 
found after the blood pressure had begun to drop. 
The electroencephalogram did not  show patterns  of convulsive discharges 
followed by EEG silence between the attacks of clonic and tonic motor convul- 
sions.  The  lack  of  EEG  changes strongly suggests that  the central nervous 
system was not directly involved in the seizures begun by the streptolysin injec- 
tions. 
ttistopathology.--Unfortunately,  the animals studied above were not examined 
histologically. However, in  some  observations  carried  out  earlier  with  less 
highly  purified streptolysin O  concentrates  (2), a  small  number of rabbits, 
fifteen, were given single large sublethal or borderline lethal doses intravenously. 
The streptolysin O  preparation  (H96-13)  was  obtained by a  modification of 
the method of Herbert and Todd (36), and contained approximately 16,000 
hemolytic units/mg, of lyophilized powder. It also revealed at least four other 
antigens detectable with human gamma globulin. One of those was identified 
as proteinase precursor, but  quantitative  estimation  with  specific antiserum 
by Dr. S. Elliot  1 showed it to be present onlyto the extent of 0.1 per cent. Other 
similar fractions, previously reported (2), but not used in these toxicity tests, 
contained 4 and 10 per cent of proteinase precursor. 
In several animals sacrificed or dying from 24 to 30 hours after injection, 
small focal inflammatory lesions were found in the ventricles consisting almost 
solely of polymorphonuclear leukocyte accumulation about apparently dam- 
aged myofibrils (see Fig.  la). Mter 2 days, the focal lesions were often more 
distinct,  and  the  muscle cell damage  more evident.  The inflammatory cells 
were mixtures of polymorphonuclear leukocytes and round cells (see Fig. lb, lc). 
At this time,  irregular cells with basophilic cytoplasm were commonly seen, 
and mitotic figures were not infrequent. At 5 or 6 days, focal healing lesions 
were noted in some instances  (Fig.  ld),  with an apparent loss of myofibrils. 
Control  sections  from  a  small  group  of  rabbits  receiving  heat-inactivated 
streptolysin O concentrate failed to show similar lesions. The possibility that 
the lesions found were due to the proteinase precursor contaminant in these 
earlier  streptolysin  concentrates  seems  almost  negligible.  Rabbits  receiving 
the reduced activated streptolysin were given a total of 0.6 mg. of lyophilized 
powder, of which roughly 0.1 per cent was proteinase. The dosage of this latter 
*  The authors are deeply grateful to Dr. S. Elliot for these estimations. S.  P.  HALBERT~  R.  BIRCHER,  AND  E.  DAHLE  779 
substance would therefore be about 0.0002  mg./kg., a  quantity much lower 
than the 1.5 mg./kg, used by Kellner in his studies (35). 
DISCUSSION 
These observations demonstrate that streptolysin O can cause extraordinarily 
rapid  effects on  the  cardiovascular  system  when  given  intravenously into 
rabbits in the reduced activated state. The finding that several multiples of 
the lethal dose can bring about almost complete electrical arrest of the heart 
in 3 to 4 seconds after completion of an injection taking 2 to 3 seconds, suggests 
that the toxic effects are felt almost as rapidly as the substance reaches the 
heart. The data accumulated in this study indicate that  streptolysin O killed 
rabbits under these conditions by means of functional damage to  the  cardiac 
muscle. The electrocardiographic changes found were characterized by conduc- 
tion defects and ventricular automatism. Similar changes have also been seen 
after toxic doses of digitalis glycosides (43).  The above observations translate 
the in mtro data of Kellner et al.  (12) to the in ~vo environment. It would be 
of interest to determine whether the electrocardiographic effects of the in vitro 
perfusion system are similar to those found here. Such studies are planned. 
The important question raised by such observations is whether they have 
any bearing on human rheumatic fever. The data described above all relate to 
acute experiments. In rheumatic fever, the disease pursues a  rather insidious 
course.  On the basis of the accumulated information, if one speculated that 
streptolysin 0  is the particular streptococcal product which causes the lesions 
of the human disease, account must be taken of three key characteristics of 
rheumatic fever. 
1.  The occurrence of a  latent period of about  1 to 3  weeks following the 
streptococcal infection, after which frank symptoms of rheumatic fever appear. 
2.  The human illness follows a  prolonged course of activity, long after the 
cessation of the initiating streptococcal infection. 
3.  The usual presence of appreciable to high titers of circulating antistrepto- 
lysin antibody. 
A  working hypothesis has been developed which incriminates streptolysin 
0  and which accounts for all of these prime characteristics of the rheumatic 
state. It is postulated that during the streptococcal infection, an abundance 
of streptolysin O (and other extracellular products) are released into the tissues 
and  the  circulation.  The  secreted  streptolysin combines  with  its  antibody 
immediately, and circulates as an antigen-antibody complex. An equilibrium 
becomes established between continued secretion of streptolysin and further 
development of the anti-streptolysin (ASO),  during the period of invasion by 
streptococci. Because of the well established, small, but definite dissociation of 
antigen-antibody  complexes (44), the streptolysin-ASO complex acts as a source 
of slow release of active streptolysin. This substance, having a  high degree of 780  CARDIOTOXICITY OF  STREPTOLYSIN  O 
predilection for certain tissues (e.g., heart, etc.), accumulates on or in the sus- 
ceptible tissue cells  until a  toxic level is reached.  At this point in time, the 
overt symptoms of rheumatic fever begin. Symptoms and damage will continue 
as long as significant amounts of streptolysin-antistreptolysin complexes are 
present to supply a source of streptolysin. 
An experimental attempt to  test this  hypothesis could be  undertaken.  It 
should be  possible  to prepare  activated streptolysin-ASO complexes in  vitro 
with the highly purified substance and naturally occurring human antibody, 
or artifically developed rabbit  antibodies.  Injection of these complexes into 
rabbits  might then be  expected to result in cumulative toxic effects similar 
to those shown above, after an appreciable latent period. Electrocardiographic 
and histopathological studies over an extended period of time could be carried 
out.  Control animals would receive non-streptococcal or other  streptococcal 
antigen-antibody complexes. 
It may also be possible to test this hypothesis to a limited extent by giving 
diets  causing  temporary hypercholesterolemia to  active  rheumatic  patients. 
It would be necessary to ascertain that the cholesterol is free to react, as serum 
cholesterol is known to be often unavailable for combining with streptolysin 
(30, 41, 42). This naturally occurring inhibitor of streptolysin may adequately 
compete with the toxin, and prevent its combination with susceptible ceils. 
Attempts to confirm Coburn's prophylactic studies with diets causing hyper- 
cholesterolemia might also be in order. Another possible test of this hypothesis 
might be undertaken in patients during an acute attack of rheumatic fever. At 
this  time, complete plasma  exchange transfusion from a  normal donor with 
low antistreptolysin titer might result in considerable elimination of the circu- 
lating streptolysin-ASO complexes. This should result in a  rapid cessation of 
the disease activity. 
It is worth pointing out again that the focal cardiac lesions Kirschner and 
Howie (16) produced in rabbits by repeated streptococcal infections appeared 
to be correlated with the antistreptolysin O titers, but not the antihyaluroni- 
dase responses. It is of interest that in the three detailed protocols recorded 
originally by  Murphy  and  Swift  (14),  a  marked  rise  in  antistreptolysin O 
response was observed terminally. Coupled with the data reported above,  it 
seems  quite  plausible  that  the focal cardiac  lesions  in  rabbits,  at  least,  are 
caused by streptolysin O. 
These studies are an integral part of a series of investigations having as their 
goal the analysis of human streptococcal infections. The observations recorded 
in  the  present  report  thus represent  the  early efforts in  characterizing  the 
biological properties of these antigens. The four streptococcal antigen prepara- 
tions tested here,  other than streptolysin, failed to cause significant electro- 
cardiographic effects, and were apparently much less toxic systemically. It is 
clear that far more extensive studies will be required, but the problem of ob- S.  P.  HALBERT,  R.  BIRCHER,  AND  E.  DAHLE  781 
taining larger quantities of the fractions must first be met. In addition, it is 
clear that future observations should preferably be carried out with the most 
highly purified fractions,  which  have met all  the varied physical,  chemical, 
and immunological criteria used at the present time for protein homogeneity. 
SUMAffARY 
1. The rapid death which occurred after  intravenous injection  of activated 
streptolysin  0 from Group A or Group C streptococci  was always preceded by 
profound electrocardiographic alterations.  After several  multiples of the LDs0 
doses, cardiac electrical  arrest  or fibrillation  could occur within 2 to 4 seconds 
after  completion of  the injection. 
2. The streptolysin  O preparations used were rather highly purified,  but were 
known to be contaminated with small amounts of one or two other immuno- 
logically  distinct  components. Evidence that the observed results  were due to 
streptolysin O was obtained by tests  of the reversibly  oxidized materials,  and 
by cholesterol  inactivation,  as well  as by in vivo  protection with human gamma 
globulin rich  in antistreptolysin  antibodies. 
3. Four non-streptolysin streptococcal  antigens,  partially  or highly purified, 
failed to produce similar electrocardiographic changes, and were much  less 
toxic.  One of these was 3 X  recrystaUized and I X  rechromatographed strepto- 
coccal proteinase. Shigella  paradysenteriae  type Ill endotoxin  also did not 
produce striking  electrocardiographic  abnormalities. 
4. A  working  hypothesis  has been developed  implicating streptolysin O 
as the etiological  streptococcal  factor  responsible  for the pathogcnesis of rheu- 
matic fever,  which seems to account for the principal  features  of this  illness. 
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EXPLANATION OF PLATE 78 
FIG. 1. Heart sections from rabbits receiving 0.6 rag. of reduced streptolysin O con- 
centrate H96-13, prepared from the C203S strain. All were fixed in Bouin's fluid,  and 
stained  with  hematoxylin  and  eosin,  except  lc which  was  stained  with  Masson's 
trichrome stain. 
FIG. 1 a. Rabbit 102-4, sacrificed  at 24 hours.  ×  385. Focal acute inflammatory re- 
action subendocardially. 
FIG. 1 b. Rabbit 101-6A, sacrificed  at 2 days.  ×  190. Portion of a rather extensive 
lesion,  right ventricle. 
FIG. 1 c. Rabbit 101-4, sacrificed  at 2 days.  ×  385. Higher magnification of a lesion 
similar to that seen in Fig. 1 b. 
FIG.  1 d. Rabbit  102-5, sacrificed  at 6 days,  ×  385.  Scar-like lesion with a single 
muscle fiber in its center. THE  JOURNAL  OF  EXPERIMENTAL  3~IEDICINE VOL. 113  PLATE  78 
(Halbert et al: Cardiotoxicity of streptolysin O) 